The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution services company. The $3,311.50 contract is for the provision of ESBRIET 267 MG CAPSULE 270S and has a completion date of March 26, 2024. Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, is the prime contractor on this award, which is not designated as a set-aside. The company also holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 2025, serving as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Generated 6/4/24, 10:10 AM